Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 19/20 | 0.61 |
| ▸ | RARG | P13631 | 19/20 | 0.61 |
| ▸ | RARA | P10276 | 18/20 | 0.61 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CRABP2 | P29373 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7638733 | 0.92 | RARA (0.53) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7633641 | 0.88 | RARA (0.50) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7806999 | 0.85 | RARA (0.78) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7640517 | 0.85 | RARB (0.67) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7157957 | 0.83 | RARB (0.72) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7637269 | 0.80 | RARA (0.43) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7633630 | 0.80 | RARB (0.62) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7642416 | 0.79 | RARB (0.71) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL8901440 | 0.78 | RARB (0.63) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL8772545 | 0.78 | RARB (0.63) | RARBRARGRARACYP26A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6355806-B1 | REGULATORS OF CELL PROLIFERATION AND DIFFERENTIATION, AGENTS FOR TREATING SKIN-RELATED DISEASES | ALLERGEN SALES, INC. | 2002-03-12 | — | — | US | disclosed |
| US-5998471-A | SKIN DISORDERS; ANTIINFLAMMATORY AGENTS | ALLERGAN SALES, INC. (US) | 1999-12-07 | — | — | US | disclosed |
| US-5808083-A | Acetylenes disubstituted with a 5 alkyl, aryl or heteroaryl substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity | ALLERGAN (US) | 1998-09-15 | — | — | US | disclosed |
| EP-0800517-A1 | ACETYLENES DISUBSTITUTED WITH A 5 OR 8 SUBSTITUTED TETRAHYDRONAPHTHYL OR DIHYDRONAPHTHYL GROUP AND WITH AN ARYL OR HETEROARYL GROUPS HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY | Allergan (US) | 1997-10-15 | — | — | EP | disclosed |
| US-5648514-A | Substituted acetylenes having retinoid-like biological activity | ALLERGAN (US) | 1997-07-15 | — | — | US | disclosed |
| WO-1996020930-A1 | ACETYLENES DISUBSTITUTED WITH A 5 OR 8 SUBSTITUTED TETRAHYDRONAPHTHYL OR DIHYDRONAPHTHYL GROUP AND WITH AN ARYL OR HETEROARYL GROUPS HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY | ALLERGAN (US) | 1996-07-11 | — | — | WO | disclosed |